Effects of the Combined Extracts of Grape Pomace and Omija Fruit on Hyperglycemia and Adiposity in Type 2 Diabetic Mice |
Cho, Su-Jung
(Department of Food Science and Nutrition, Kyungpook National University)
Jung, Un Ju (Department of Food Science and Nutrition, Kyungpook National University) Kim, Hye-Jin (Food R&D, CJ Cheiljedang Corp.) Ryu, Ri (Department of Food Science and Nutrition, Kyungpook National University) Ryoo, Jae Young (School of Life Sciences, Kyungpook National University) Moon, Byoung Seok (Food R&D, CJ Cheiljedang Corp.) Choi, Myung-Sook (Department of Food Science and Nutrition, Kyungpook National University) |
1 | Wang XY, Yu ZL, Pan SY, Zhang Y, Sun N, Zhu PL, Jia ZH, Zhou SF, Ko KM. 2014. Supplementation with the extract of Schisandrae Fructus pulp, seed, or their combination influences the metabolism of lipids and glucose in mice fed with normal and hypercholesterolemic diet. Evid Based Complement Alternat Med 2014: 472638. |
2 | Cho SJ, Jung UJ, Park HJ, Kim HJ, Park YB, Kim SR, Choi MS. 2013. Combined ethanol extract of grape pomace and omija fruit ameliorates adipogenesis, hepatic steatosis, and inflammation in diet-induced obese mice. Evid Based Complement Alternat Med 2013: 212139. |
3 | Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L. 2000. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of western diet feeding. Metabolism 49: 22-31. DOI ScienceOn |
4 | Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509. |
5 | Hulcher FH, Oleson WH. 1973. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J Lipid Res 14: 625-631. |
6 | Davidson AL, Arion WJ. 1987. Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity. Arch Biochem Biophys 253: 156-167. DOI ScienceOn |
7 | Alegre M, Ciudad CJ, Fillat C, Guinovart JJ. 1988. Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction. Anal Biochem 173: 185-189. DOI |
8 | Bentle LA, Lardy HA. 1976. Interaction of anions and divalent metal ions with phosphoenolpyruvate carboxykinase. J Biol Chem 251: 2916-2921. |
9 |
Davies GF, Khandelwal RL, Wu L, Juurlink BH, Roesler WJ. 2001. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: a peroxisome proliferator- activated receptor- |
10 | Tataranni PA, Ortega E. 2005. A burning question: does an adipokine-induced activation of the immune system mediate the effect of overnutrition on type 2 diabetes? Diabetes 54: 917-927. DOI ScienceOn |
11 | Paquot N, Tappy L. 2005. Adipocytokines: link between obesity, type 2 diabetes and atherosclerosis. Rev Med Liege 60: 369-373. |
12 | Tong J, Fujimoto WY, Kahn SE, Weigle DS, McNeely MJ, Leonetti DL, Shofer JB, Boyko EJ. 2005. Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10-year follow-ups in nondiabetic Japanese Americans. Diabetes 54: 985-990. DOI ScienceOn |
13 | Steppan CM, Lazar MA. 2002. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 13: 18-23. DOI ScienceOn |
14 | Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. 1997. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature 389: 374-377. DOI ScienceOn |
15 | Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. 2001. The hormone resistin links obesity to diabetes. Nature 409: 307-312. DOI ScienceOn |
16 | Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. 2001. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935. DOI |
17 |
Lazarow PB. 1981. Assay of peroxisomal |
18 | Leahy JL. 2005. Pathogenesis of type 2 diabetes mellitus. Arch Med Res 36: 197-209. DOI ScienceOn |
19 | Matsuzawa Y, Funahashi T, Nakamura T. 1999. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines . adipocyte-derived bioactive substances. Ann NY Acad Sci 892: 146-154. DOI |
20 | Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254. DOI ScienceOn |
21 | Nepokroeff CM, Lakshmanan MR, Porter JW. 1975. Fatty acid synthase from rat liver. Mothods Enzymol 35: 37-44. DOI |
22 | Pitkanen E, Pitkanen O, Uotila L. 1997. Enzymatic determination of unbound D-mannose in serum. Eur J Clin Chem Clin Biochem 35: 761-766. |
23 | Ochoa S. 1955. "Malic" enzyme. A. "Malic" enzyme from pigeon liver and wheat germ. Methods Enzymol 1: 739-753. DOI |
24 |
Walton PA, Possmayer F. 1985. |
25 | Chen H, Charlat O, Tartaglia LA, Woolf EA, Weng X, Ellis SJ, Lakey ND, Culpepper J, Moore KJ, Breitbart RE, Duyk GM, Tepper RI, Morgenstern JP. 1996. Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell 84: 491-495. DOI ScienceOn |
26 | Nishina PM, Lowe S, Wang J, Paigen B. 1994. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow. Metabolism 43: 549-553. DOI ScienceOn |
27 | Lombardo YB, Hron WT, Sobocinski KA, Menahan LA. 1984. A metabolic profile of fed and fasting genetically obese mice at 4-5 months of age. Horm Metab Res 16: 37-42. DOI |
28 | Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR. 2000. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6: 87-97. DOI ScienceOn |
29 | Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. 1996. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97: 2859-2865. DOI ScienceOn |
30 | Rajala MW, Scherer PE. 2003. Minireview: The adipocyte− at the crossroads of energy homeostasis, inflammation, and atherosclersis. Endocrinology 144: 3765-3773. DOI ScienceOn |
31 | DeFronzo RA. 1999. Pharmacologic therapy for type 2 diabetes mellitus. Ann Intern Med 131: 281-303. DOI ScienceOn |
32 | Takahashi Y, Soejima Y, Fukusato T. 2012. Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 18: 2300-2308. DOI ScienceOn |
33 | Perez-Jimenez J, Saura-Calixto F. 2008. Grape products and cardiovascular disease risk factors. Nutr Res Rev 21: 158-173. DOI ScienceOn |
34 | Cordain L, Melby CL, Hamamoto AE, O'Neill DS, Cornier MA, Barakat HA, Israel RG, Hill JO. 2000. Influence of moderate chronic wine consumption on insulin sensitivity and other correlates of syndrome X in moderately obese women. Metabolism 49: 1473-1478. DOI ScienceOn |
35 | Ceriello A, Bortolotti N, Motz E, Lizzio S, Catone B, Assaloni R, Tonutti L, Taboga C. 2001. Red wine protects diabetic patients from meal-induced oxidative stress and thrombosis activation: a pleasant approach to the prevention of cardiovascular disease in diabetes. Eur J Clin Invest 31: 322-328. DOI ScienceOn |
36 | Jo SH, Ha KS, Moon KS, Lee OH, Jang HD, Kwon YI. 2011. In vitro and in vivo anti-hyperglycemic effects of omija (Schizandra chinensis) fruit. Int J Mol Sci 12: 1359-1370. DOI ScienceOn |
37 | Likimani TA, Wilson RP. 1982. Effects of diet on lipogenic enzyme activities in channel catfish hepatic and adipose tissue. J Nutr 112: 112-117. DOI |
38 | Schaffler A, Scholmerich J, Buchler C. 2005. Mechanisms of disease: adipocytokines and visceral adipose tissue− emerging role in nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2: 273-280. DOI ScienceOn |
39 | Diraison F, Dusserre E, Vidal H, Sothier M, Beylot M. 2002. Increased hepatic lipogenesis but decreased expression of lipogenic gene in adipose tissue in human obesity. Am J Physiol Endocrinol Metab 282: E46-E51. DOI |
40 | Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. 2003. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285: E906-E916. DOI ScienceOn |
41 |
Miedema K. 2004. Towards worldwide standardisation of |
42 |
Kasuga M. 2006. Insulin resistance and pancreatic |
43 |
Prentki M, Nolan CJ. 2006. Islet |
44 | Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Kempf J, Zinman B, Haffner SM. 2004. Elevations in markers of liver injury and risk of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 53: 2623-2632. DOI ScienceOn |
45 | Reaven GM. 1988. Role of insulin resistance in human disease. Diabetes 37: 1595-1607. DOI |
![]() |